Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer to buy Seagen in $43B cancer drug deal
BioPharma Dive
Mon, 03/13/23 - 10:57 am
Tags:
Pfizer, Seagen, M&A, lymphoma, Adcetris
Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval
BioSpace
Fri, 03/10/23 - 11:32 am
Tags:
Pfizer, Biohaven, FDA, migraines, nasal spray, zavegepant, Zavzpret
Pfizer ready to launch RSV vaccines for older adults, pregnant women in US, Europe
Reuters
Fri, 03/10/23 - 09:51 am
Tags:
Pfizer, GSK, vaccines, RSV
Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business
Motley Fool
Thu, 03/9/23 - 11:28 am
Tags:
Pfizer, Seagen, M&A
Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections
Stat
Thu, 03/9/23 - 09:56 am
Tags:
Pfizer, Pharma CEOs, Albert Bourla, political contributions
Pfizer (PFE) or GSK: Who Will Get the First FDA Nod for RSV Jab?
Yahoo/Zacks.com
Wed, 03/8/23 - 09:30 am
Tags:
GSK, Pfizer, FDA, vaccines, RSV
Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children
PM Live
Thu, 03/2/23 - 10:01 am
Tags:
Pfizer, BioNTech, FDA, COVID-19, boosters, vaccines, pediatric
Tempus, Pfizer partner for cancer drug development
Pharmaceutical Business Review
Wed, 03/1/23 - 09:46 am
Tags:
Pfizer, Tempus, cancer, drug development, artificial intelligence, machine learning
Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions
Fierce Biotech
Tue, 02/28/23 - 10:56 pm
Tags:
Pfizer, RSV, vaccines, Abrysvo, FDA
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
Tags:
FDA, Acadia Pharmaceuticals, Apellis Pharmaceuticals, AstraZeneca, Biogen, Biomarin, Cidara Therapeutics, Emergent BioSolutions, GSK, Incyte, Ionis Pharmaceuticals, Melinta Therapeutics, Mundipharma, Novartis, Pfizer, Pharming, Regeneron, Roche, vaccines, RSV, ALS, COVID-19
Seagen has a New Suitor as Pfizer Talks Begin
BioSpace
Mon, 02/27/23 - 10:21 am
Tags:
Seagen, Pfizer, M&A
Pfizer spinout SpringWorks gets FDA priority review for lead drug
Endpoints
Mon, 02/27/23 - 10:14 am
Tags:
SpringWorks Therapeutics, Pfizer, nirogacestat, desmoid tumors, FDA, priority review
Pfizer and BioNTech file BLA for Omicron-targeting Covid-19 vaccine
Endpoints
Sun, 02/26/23 - 10:05 pm
Tags:
Pfizer, BioNTech, COVID-19, Omicron, vaccines, FDA
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
Motley Fool
Thu, 02/23/23 - 10:30 am
Tags:
Pfizer, earnings, vaccines, COVID-19
Pfizer shedding more than 100 jobs at its San Diego research and development center
San Diego Union Tribune, CA
Wed, 02/22/23 - 06:48 pm
Tags:
Pfizer, layoffs, R&D, California, San Diego
‘No Time to Wait’ Ad Campaign from BMS-Pfizer Features Basketball Legend Kareem Abdul-Jabbar for AFib Awareness
Xtalks
Wed, 02/22/23 - 10:01 am
Tags:
Pfizer, BMS, atrial fibrillation, celebrity endorsements, DTC advertising, television ads
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Tags:
Pfizer, RSV, vaccines, GSK, AstraZeneca, Sanofi, RSVpreF
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
Tags:
RSV, vaccines, GSK, Pfizer, Sanofi, Sobi, Moderna Therapeutics, AstraZeneca, JNJ, FDA
Pfizer, Valneva remove half of participants from study of Lyme disease shot
BioPharma Dive
Fri, 02/17/23 - 11:27 am
Tags:
Pfizer, Valneva, clinical trials, vaccines, Lyme disease, VLA15
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
Fri, 02/17/23 - 09:36 am
Tags:
ASCO GU, Pfizer, Astellas, Xtandi, prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.